GE
Therapeutic Areas
AKIGAI Pipeline
| Drug | Indication | Phase |
|---|---|---|
| EGFR Inhibitor (Tyrosine Kinase Inhibitor - oral) | Chronic Neuropathic Pain | Preclinical |
| EGFR Inhibitor (Monoclonal Antibody - parenteral) | Chronic Neuropathic Pain | Preclinical |
| Modified/Targeted EGFR Inhibitor | Chronic Neuropathic Pain | Discovery |
Leadership Team at AKIGAI
CK
Christian Kersten
MD PhD, Co-Founder, Clinical Oncologist, Researcher, Inventor
MC
Marte Cameron
MD PhD, Co-Founder, Clinical Oncologist, Researcher, Inventor
GS
Gry Stensrud
Chief Technical Officer (CTO) & Chief Organizational Officer (COO)
MK
Morten Kompen
Chief Financial Officer (CFO)
SN
Stig Nordal
LLM, MoM, MTM, Partner at DLA Piper's IPT Group, Advisor
GA
Gerard Akkerhuis
MD, Business Development Advisor